Maria Irujo
Formulation & Pharmaceutical Innovation Advanced Biodesign
PhD in Pharmaceutical Sciences (CIFRE, Advanced Biodesign & CEA-Leti), she specialises in lipid formulation and drug product development. With multidisciplinary expertise spanning characterisation, in vitro studies, and CMC project coordination, she translates innovative research into viable therapeutic candidates.
Seminars
Thursday 24th September 2026
Debate: Which Strategy Will Truly Break Liver Tropism & Enable Clinically Viable Extrahepatic Delivery
11:30 am
3–4 speakers each briefly defend a different approach in this open debate. The audience votes on the most promising strategy.
- Lipid chemistry vs formulation tuning vs hybrid systems
- Passive biodistribution control vs active targeting (ligands, peptides, etc.)
- Incremental optimisation vs completely new delivery paradigms
- What actually translates in vivo vs what only works in preclinical models
